Articles about 'Alzheimer's Research UK'

Gene therapy technique shows potential for repairing damage caused by glaucoma and dementia

31 March 2021

Scientists at the University of Cambridge have shown in animal studies that gene therapy may help repair some of the damage caused in chronic neurodegenerative conditions such as glaucoma and dementia. Their approach demonstrates the potential effectiveness of gene therapy in polygenic conditions – that is, complex conditions with no single genetic cause.

Blood pressure drug shows promise for treating Parkinson’s and dementia in animal studies

18 April 2019

A prescription drug to treat high blood pressure has shown promise against conditions such as Parkinson’s, Huntington’s and forms of dementia in studies carried out in mice and zebrafish at the University of Cambridge.

Tyrosine hydroxylase positive neuron stained with a synaptic marker

Calcium may play a role in the development of Parkinson’s disease

19 February 2018

Researchers have found that excess levels of calcium in brain cells may lead to the formation of toxic clusters that are the hallmark of Parkinson’s disease.

Dementia: Catching the memory thief

21 September 2016

It's over a hundred years since the first case of Alzheimer’s disease was diagnosed. Since then we’ve learned a great deal about the protein ‘tangles’ and ‘plaques’ that cause the disease. How close are we to having effective treatments – and could we even prevent dementia from occurring in the first place?

Researchers identify ‘neurostatin’ that may reduce the risk of Alzheimer’s disease

12 February 2016

An approved anti-cancer drug successfully targets the first step in the toxic chain reaction that leads to Alzheimer’s disease, suggesting that treatments may be found to lower the risk of developing the neurodegenerative condition.

Link between proteins points to possibilities for future Alzheimer’s treatments

23 April 2015

Researchers have identified how proteins that play a key role in Alzheimer’s disease are linked in a pathway that controls its progression, and that drugs targeting this pathway may be a potential new way of treating the disease.

Cambridge Drug Discovery Institute to fast-track development of new treatments for dementia

16 February 2015

Alzheimer’s Research UK, the world’s largest dedicated dementia research charity, has announced a £30 million Drug Discovery Alliance, launching three flagship Drug Discovery Institutes at the Universities of Cambridge, Oxford and UCL (University College London). The Drug Discovery Institutes will see 90 new research scientists employed in state-of-the-art facilities to fast-track the development of new treatments for Alzheimer’s disease and other dementias.

Scientists wake up to causes of sleep disruption in Alzheimer’s disease

27 February 2014

New research using fruit flies with Alzheimer’s protein finds that the disease doesn’t stop the biological clock ticking, but detaches it from the sleep-wake cycle that it usually regulates. Findings could lead to more effective ways to improve sleep patterns in those with Alzheimer’s.

Articles about 'Alzheimer's Research UK'

Gene therapy technique shows potential for repairing damage caused by glaucoma and dementia

Blood pressure drug shows promise for treating Parkinson’s and dementia in animal studies

Calcium may play a role in the development of Parkinson’s disease

Dementia: Catching the memory thief

Researchers identify ‘neurostatin’ that may reduce the risk of Alzheimer’s disease

Link between proteins points to possibilities for future Alzheimer’s treatments

Cambridge Drug Discovery Institute to fast-track development of new treatments for dementia

Scientists wake up to causes of sleep disruption in Alzheimer’s disease

Connect with us

Study at Cambridge

About the University

Research at Cambridge

Articles about 'Alzheimer's Research UK'

Pages